Join to view full profile
995 Potrero AveBldg 80San Francisco, CA 94110
Phone+1 415-476-4082
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen Sherwin, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California, Maryland, and New York.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
Harvard Medical SchoolClass of 1974
Certifications & Licensure
NY State Medical License 1975 - Present
CA State Medical License 1980 - 2027
MD State Medical License 1976 - 1991
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 257 citationsSafety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.Kristen Hege, Emily K. Bergsland, George A. Fisher, John Nemunaitis, Robert S. Warren
Journal for Immunotherapy of Cancer. 2017-03-21 - BIO's track record on emerging companiesRachel King, Stephen A Sherwin
Nature Biotechnology. 2010-05-01 - 2 citationsWe speak for small biotech.Stephen A Sherwin
Nature Biotechnology. 2008-01-01
Press Mentions
NEUVOGEN Appoints Stephen a. Sherwin, M.D. To Its Scientific Advisory BoardJuly 25th, 2022
Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory BoardJanuary 26th, 2017
Third Rock Ventures Closes Fund IV at $616MNovember 3rd, 2016
